Crossmark

Elucidating the risk of cardiopulmonary consequences of an exacerbation of COPD: results of the EXACOS-CV study in Germany

Crossref DOI link: https://doi.org/10.1136/bmjresp-2023-002153

Published Online: 2024-03-30

Published Print: 2024-03

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Vogelmeier, Claus F

Rhodes, Kirsty

Garbe, Edeltraut

Abram, Melanie

Halbach, Marija

Müllerová, Hana

Kossack, Nils

Timpel, Patrick https://orcid.org/0000-0002-5158-0178
Kolb, Nikolaus https://orcid.org/0009-0002-8733-0821
Nordon, Clementine
Funding

Funding for this research was provided by:

AstraZeneca
License Information

License valid from 2024-03-29